Letter in response to the recently published review: hyponatremia in cirrhosis and end-stage liver disease--treatment with the vasopressin v2-receptor antagonist tolvaptan

MeSH terms

• Benzazepines / therapeutic use*
• End Stage Liver Disease / complications*
• End Stage Liver Disease / drug therapy*
• Humans
• Hyponatremia / drug therapy*
• Hyponatremia / etiology*
• Liver Cirrhosis / complications*
• Liver Cirrhosis / drug therapy*